Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction.

European heart journal·2021

Same author

The exercise pressor response to indoor rock climbing.

Journal of applied physiology (Bethesda, Md. : 1985)·2020

Same author

Clinical characteristics and survival in cardiogenic shock admissions to a UK heart transplant unit.

Future cardiology·2018

Same author

Letter to the Editor: "Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials".

The Journal of clinical endocrinology and metabolism·2017

Same author

The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future.

Postgraduate medical journal·2016

Same author

Prolonged asystole in a patient with an isolated left ventricular assist device.

Future cardiology·2016

Search research articles

Related Experiment Videos

Current issues in thromboprophylaxis in the elderly.

Parminder S Chaggar¹, Kevin S Channer

¹Cardiothoracic Transplant Centre, Wythenshawe Hospital, Manchester, United Kingdom.

|November 22, 2008

Summary

Elderly patients often miss out on essential thromboprophylaxis due to overestimated bleeding risks. This review highlights the favorable risk-benefit profile of thromboprophylaxis in older adults, advocating for comprehensive strategies.

Related Experiment Videos

Area of Science:

Geriatrics
Cardiovascular Medicine
Pharmacology

Background:

Elderly individuals face high risks of arterial and venous thromboembolism, leading to significant morbidity and mortality.
Inadequate thromboprophylaxis is common in the elderly due to overestimated bleeding concerns, denying them proven antithrombotic benefits.
Current guidelines recommend comprehensive thromboprophylactic strategies for all age groups, including specific considerations for the elderly.

Purpose of the Study:

To discuss the latest developments and current opinions on thromboprophylaxis.
To emphasize the relevance of thromboprophylaxis in the elderly population.
To review the safety and efficacy of pharmacological thromboprophylaxis in older adults.

Main Methods:

Review of current literature and guidelines on thromboprophylaxis.
Analysis of risk-benefit profiles of antithrombotic regimens in elderly cohorts.
Discussion of new anticoagulant drugs and their potential in elderly populations.

Main Results:

Pharmacological thromboprophylaxis demonstrates a favorable risk-benefit profile, even in elderly populations.
Recent studies confirm the safety and efficacy of thromboprophylaxis in both surgical and medical patients, including elderly individuals.
Newer anticoagulant agents show promise with potentially lower bleeding risks and reduced monitoring needs.

Conclusions:

Thromboprophylaxis is crucial for reducing thromboembolic events in the elderly.
Overestimation of bleeding risk should not preclude appropriate thromboprophylaxis in older adults.
Ongoing research and development of novel anticoagulants aim to improve safety and efficacy for this vulnerable population.